Ross Moat, COO of Kiniksa Pharmaceuticals International KNSA, has filed 0 purchases and 11 sales on the open market. Over the past 12 months that comes to a net sale of $194.5K. The latest trade was on 04/09.

Ross Moat

COO

Company: Kiniksa Pharmaceuticals International KNSA
First filing: 23/03/20

Trades: 123 trades
Buys / sales: 0 / 11
12-month net buying: −$194.5K
Last trade: 04/09

Trading activity

Transactions

	Trade type
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	04/09	04/13	1,703 sh	$46.69	$79,513.07	−12.4%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	04/06	04/08	2,367 sh	$48.58	$114,988.86	−16.4%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/09/04	25/09/08	3,523 sh	$35.31	$124,397.13	−27.2%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/06/03	25/06/05	27,594 sh	$29.02	$800,777.88	−74.6%
KNSA	Open-market sale10b5-1 plan	25/05/02–25/05/05	25/05/05	10,122 sh2 trades	$28.00avg.	$283,416	−51.8%
KNSA	Open-market sale10b5-1 plan	25/04/29–25/05/01	25/05/01	87,269 sh2 trades	$25.96avg.	$2,265,339.03	−90.3%
Kiniksa Pharmaceuticals InternationalKNSA	Open-market sale10b5-1 plan	25/04/21	25/04/23	18,259 sh	$20.29	$370,475.11	−66.0%
KNSA	Open-market sale10b5-1 plan	24/09/03	24/09/04	68,506 sh2 trades	$26.12avg.	$1,789,189.8	−75.9%